A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Clinical Pathology, 68, 12, S. 1044.1-1046
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2015
- Event
-
Veröffentlichung
- (who)
-
BMJ
- (when)
-
2015
- Creator
- DOI
-
10.1136/jclinpath-2015-202996
- URN
-
urn:nbn:de:bvb:384-opus4-1029348
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eisner, Florian
- Pichler, Martin
- Goletz, Steffen
- Stoeger, Herbert
- Samonigg, Hellmut
- Universität Augsburg
- BMJ
Time of origin
- 2015
Other Objects (12)
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells